Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

Trial Profile

Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Erythropoietin (Primary)
  • Indications Optic neuritis
  • Focus Therapeutic Use
  • Acronyms TONE
  • Most Recent Events

    • 11 Oct 2017 Planned End Date changed from 1 Sep 2019 to 1 Oct 2019.
    • 11 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Apr 2018.
    • 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top